Education, Science, Technology, Innovation and Life
Open Access
Sign In

The Mechanism of Scutellarin on Pancreatic Cancer Cells was Studied Based on Network Pharmacology

Download as PDF

DOI: 10.23977/medcm.2023.050210 | Downloads: 10 | Views: 373

Author(s)

Zixin Xu 1, Faping Song 1, Shuangquan Wang 1,2

Affiliation(s)

1 Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, 712046, China
2 The Third Affiliated Hospital of Shaanxi University of Chinese Medicine, Xi'an XD Group Hospital, Xi'an, Shaanxi, 710077, China

Corresponding Author

Shuangquan Wang

ABSTRACT

Objective: To explore the potential target and mechanism of action of scutellarin in the treatment of pancreatic cancer by network pharmacology. Methods: Swiss Target Prediction was used to extract the potential target of scutellarin. The targets of pancreatic cancer were obtained from Gene Cards and OMIM databases. R software was used to analyze and obtain common targets of drugs and diseases. Cytoscope3.7.2 software plug-in CtyoNCA topology was used to establish the protein interaction (PPI) network diagram using STRING database to analyze the key targets of drug therapy in disease. R software was used for GO enrichment analysis. The Metascape website was used for enrichment analysis of KEGG pathway to predict the signaling pathway of scutellarin in the treatment of pancreatic cancer. Results: A total of 91 targets related to scutellarin in the treatment of pancreatic cancer were screened, including TNF, EGFR, CASP3, HSP90AA1, HRAS, etc. By GO enrichment analysis, 932 items were obtained, including 797 BP, 58 CC, and 77 MF. Through KEGG enrichment analysis, we obtained 13 tumor-related KEGG pathways, including anti-folate resistance, C-type lectin receptor signaling pathway, nitrogen metabolism, galactose metabolism, cancer pathway, neural active ligand-receptor interaction, purine metabolism, etc. Conclusion: This study indicates that scutellarin can act on pancreatic cancer through multiple targets and pathways. Scutellarin has a potential therapeutic effects on pancreatic cancer. This study provides a new basis for curcumin in the treatment of pancreatic cancer.

KEYWORDS

Pharmacology of network, Scutellarin, Pancreatic cancer, PPI, GO, KEGG

CITE THIS PAPER

Zixin Xu, Faping Song, Shuangquan Wang, The Mechanism of Scutellarin on Pancreatic Cancer Cells was Studied Based on Network Pharmacology. MEDS Chinese Medicine (2023) Vol. 5: 75-82. DOI: http://dx.doi.org/10.23977/medcm.2023.050210.

REFERENCES

[1] Herszényi L, Tulassay Z. Epidemiology of gastrointestinal and liver tumors. Eur Rev Med Pharmacol Sci. 2010; 14(4):249-258. 
[2] Li Zhaoshen, Yu Zhiliang, Zhou Guozhong, Zou Xiaoping, He Jia, Cai Quancai, Hu Xiangui, Wang Qiang. Analysis of misdiagnosis factors of pancreatic cancer. Journal of PLA Medicine, 2002 (04): 304-306.
[3] Martucci D, Masseroli M, Pinciroli F. Gene ontology application to genomic functional annotation, statistical analysis and knowledge mining. Studies in health technology and informatics, 2004, 102:108-131.
[4] Lee JH, Miele ME, Hicks DJ, et al. KiSS-1, a novel human malignant melanoma metastasis-suppressor gene [published correction appears in J Natl Cancer Inst 1997 Oct 15;89(20):1549. J Natl Cancer Inst. 1996; 88(23): 1731-1737. doi:10.1093/jnci/88.23.1731
[5] Xu Yanli, Liu Luming, Chen Hao, Hua Yongqiang. Academic thought and experience of Professor Liu Luming in treating pancreatic cancer  Chinese Journal of Traditional Chinese Medicine, 2012,30 (12): 2628-2630. DOI: 10. 13193 /j archtcm.2012.12.38.xuyl.015.
[6] Tang Lei, Lu Chenchun, Wang Liwei. Zhou Weishun's experience in treating pancreatic cancer based on syndrome differentiation. Zhejiang Journal of Integrated Traditional and Western Medicine, 2010, 20 (03): 137.
[7] Lei Nan, Xiong Sihui, Tan Li, He Man, Zhang Meng, Sun Qiang, Zeng Sha, Chen Li, Zhou Lijuan, Xu Haibo. Study on inhibition of colon cancer stem cell differentiation by scutellarin through hedgehog signal pathway. Chinese Journal of Traditional Chinese Medicine, 2020, 45(07):1676-1683.DOI:10.19540/j.cnki.cjcmm.20200108.401. 
[8] Li Detao, Zhang Yuting, Hou Yulei. Serum tumor necrosis factor in patients with lung cancer- α Detection and significance of. Journal of Practical Laboratory Physicians, 2022-14 (02): 182-185.
[9] Ma Yu, Li Yan, Luo Yali, Wang Biwen, Zhou Xiaotian, Zhou Shiqin, Zhou Wen. Tumor necrosis factor- α Role in chronic inflammation and tumorigenesis. Chinese Journal of Clinical Pharmacology, 2022, 38(12): 419- 1423. DOI: 10. 13699/ j.cnki.1001-6821.2022.12.027
[10] Cao Ting, Zhang Chao, Hu Ling, Jiang Binyuan, Hu Jinyue. TNF α Study on the molecular mechanism of inducing STAT3 signal transduction. Chinese Journal of Cell Biology, 2022, 44(02):239-247.
[11] Zhong Houcheng, Zhu Yufan, Yang Min, Wei Renxiong. Homoharringtonine inhibits osteosarcoma cell lines by up regulating the expression of casp3 and casp8. Biological orthopedic materials and clinical research, 2022, 19(04):8-15.
[12] Jia Zhen, Yu Lifeng, Wei Qian, Zhao Lin. Analysis of HSP90AA1 expression and prognosis in breast cancer based on TCGA data. Progress in anatomical science, 2020, 26(03): 347- 349+ 353. DOI: 10. 16695/ j. cnki. 1006- 2947. 2020. 03.028
[13] Huang Mingju, Wang Qi, Zhang Wei, Yin Qiaoyun, Li Xiang, Li Li. Detection of folate binding protein expression in ovarian malignant tumors and its clinical significance. Chinese Journal of Cancer, 2012, 22(01):25-30.
[14] Wishart, David S. Is Cancer a Genetic Disease or a Metabolic Disease?. EBioMedicine, 2015, 2(6):478-479
[15] Chen Bingyu, Huang Sizhou. Research progress on the role of one carbon metabolism pathway in carcinogenesis. Chinese Journal of Cell Biology, 2019, 41(06):1201-1206.
[16] Lee, J. S., Adler, L., Karathia, H., Carmel, N., Rabinovich, S., Auslander, N., Keshet, R., Stettner, N., Silberman, A., Agemy, L., Helbling, D., Eilam, R., Sun, Q., Brandis, A., Malitsky, S., Itkin, M., Weiss, H., Pinto, S., Kalaora, S., Levy, R., … Erez, A. (2018). Urea Cycle Dysregulation Generates Clinically Relevant Genomic and Biochemical Signatures. Cell, 174(6), 1559–1570.e22. https://doi.org/10.1016/j.cell.2018.07.019
[17] Mandal P. (2018). Insight of nitric oxide signaling: A potential biomarker with multifaceted complex mechanism in colorectal carcinogenesis. Biochemical and biophysical research communications, 495(2), 1766–1768. https: // doi. org/ 10.1016/j.bbrc.2017.12.051
[18] Wang Wanpeng, Yu Ran, Zhou Suqin, Song Jian, Luo Anqing, Pu Juan, Bu Yanzhi. Chromosome 4 open reading frame 19 participates in the malignant phenotype of colorectal adenocarcinoma by regulating nitrogen metabolism. Chinese Journal of Experimental Surgery, 2021, 38(09):1781-1783.
[19] Yang Yunning, Xu Yuanyuan, Long Shan, Li Xiaosong. Research progress of C-type lectin receptor in tumor immunity. Chinese Journal of Immunology, 2019, 35(09):1139-1142.
[20] Sancho D., Mourão-Sá D., Joffre O. P., Schulz O., Rogers N. C., Pennington D. J., Carlyle J. R., & Reis e Sousa, C. (2008). Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin. The Journal of clinical investigation, 118(6), 2098–2110. https://doi.org/10.1172/JCI34584
[21] Yan H., Kamiya T., Suabjakyong P., & Tsuji N. M. (2015). Targeting C-Type Lectin Receptors for Cancer Immunity. Frontiers in immunology, 6, 408. https://doi.org/10.3389/fimmu.2015.00408
[22] Li B., Cai Y., Qi C., Hansen R., Ding C., Mitchell T. C., & Yan J. (2010). Orally administered particulate beta-glucan modulates tumor-capturing dendritic cells and improves antitumor T-cell responses in cancer. Clinical cancer research: an official journal of the American Association for Cancer Research, 16(21), 5153–5164. https://doi.org/10.1158/1078-0432.CCR-10-0820

Downloads: 4243
Visits: 168286

Sponsors, Associates, and Links


All published work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2016 - 2031 Clausius Scientific Press Inc. All Rights Reserved.